Glenmark Pharmaceuticals Limited
had issued the FCC Bonds in 2016 which are currently listed on the Singapore Exchange Securities Trading Limited. The Company has purchased an aggregate principal amount of US$ 1,000,000 of the FCC Bonds at a repurchase price of 120.30% of the principal amount at an aggregate purchase price of US$ 1,203,000.00 plus accrued but unpaid interest and additional interest.
“Pursuant to the aforementioned repurchase, an aggregate principal amount of US$ 75,750,000 of the FCC Bonds currently remain outstanding,” the company said in a filing on Wednesday.
At around 12.04 pm, Glenmark Pharmaceuticals Limited was trading at Rs537.90 per piece up Rs2.30 or 0.43% on the BSE.